|
Robert Perkins is Vice President, Public Policy at AstraZeneca Pharmaceuticals. In his role, Mr. Perkins is responsible for evaluating and assessing the impact of public policy forces and developing and reconciling strategic options to enhance the company’s image, presence, market penetration and reach, based on insights from internal and external analysis.
Mr. Perkins joined AstraZeneca after serving as the first Executive Director of Together RxÔ LLC from January 2003 – August 2004. He led operations, strategic planning and enrollment expansion efforts for the rapidly growing prescription savings program, which was established in 2002.
Prior to joining Together Rx, Mr. Perkins held senior positions in Government Affairs, Public Policy and Business Operations at DuPont Pharmaceuticals Co., including Senior Vice President of Public Policy, and Vice President of Government and Public Affairs and Pharmaceutical Administration. While at DuPont, he was twice the recipient of the Summit Award, the company’s highest honor, as well as the Work-Life Award for management ability.
From 1988 to 1993, Mr. Perkins was Chief Operating Officer at Richards, Layton & Finger, P.A., Delaware’s largest law firm. From 1981 to 1986, he served as Press Secretary and Chief of Staff for Delaware Governor Pierre S. du Pont IV and Governor Michael N. Castle.
A native of New Jersey, Mr. Perkins received a B.A. in English Literature from Lynchburg College in Lynchburg, Virginia, and has completed a program for senior executives in local and state government at Harvard University’s John F. Kennedy School of Government.
He has been active in a number of professional and civic organizations, including the Board of Directors of Easter Seals of Delaware, and the Delaware Public Policy Institute.
|
